Science-based micronized palmitoylethanolamide for pain management
Palmitoylethanolamide (PEA) is a member of the endocannabinoid fatty acid amides and exhibits potent anti-inflammatory and analgesic properties. Extensive clinical evidence supports the pleiotropic effects of PEA, where it appears to exert it’s therapeutic effects via more than one mode of action, by modulating the endocannabinoid system in a safer and therapeutically efficacious manner.
PEA is typically poorly water-soluble which affects oral absorption and bioavailability. Micronization helps reduce large PEA particles to the micron range (<10 μm), providing a larger total surface area and enables rapid dissolution and therapeutic efficacy corroborated by preclinical evidence.
NFH Pain Relief SAP:
Gluten, soy, wheat, eggs, dairy, yeast, citrus, preservatives, artificial colours and flavours, starch, or sugar.
Adults: Take 2-4 capsules daily or as directed by your healthcare practitioner.
May take up to two weeks to notice the beneficial effects. Take daily for a minimum of two weeks for chronic pain relief.
Each vegetable capsule contains:
|Palmitoylethanolamide (micronized)||300 mg|
|Devil’s claw (Harpagophytum procumbens) extract, 5% harpagosides||30 mg|